Croce S, Hostein I, McCluggage WG (2021Mar) NTRK and other recently described kinase fusion positive uterine sarcomas: a review of a group of rare neoplasms. Genes Chromosomes Cancer 60(3):147–159
Article CAS PubMed Google Scholar
Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, Park KJ, Soslow RA, Oliva E, Iafrate AJ, Benayed R, Ladanyi M, Antonescu CR (2018Jun) NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma. Am J Surg Pathol 42(6):791–798
Article PubMed PubMed Central Google Scholar
Devereaux KA, Weiel JJ, Mills AM, Kunder CA, Longacre TA (2021May 1) Neurofibrosarcoma revisited: an institutional case series of uterine sarcomas harboring kinase-related fusions with report of a novel FGFR1-TACC1 fusion. Am J Surg Pathol 45(5):638–652
Weisman PS, Altinok M, Carballo EV et al (2020) Uterine cervical sarcoma with a novel RET-SPECC1L fusion in an adult: a case which expands the homology between RET-rearranged and NTRK-rearranged tumors. Am J Surg Pathol 44:567–570
Lin D, Huang RSP, Ross JS, Elvin JA, Williams EA (2023) Recurrent activating ERBB2 V777L point mutation in fusion-negative, S100 and SOX10-positive uterine (corpus and cervix) spindle cell neoplasms. Lab Invest 103(3, Supplement 100091):S941–S942
Agaimy A, Dermawan JK, Haller F, Semrau S, Meidenbauer N, Stoehr R, Lax S, Hartmann A, Zou YS, Xing D, Tögel L, Gross JM, Michal M (2024) ERBB2/ ERBB3-mutated S100/ SOX10-positive unclassified high-grade uterine sarcoma: first detailed description of a novel entity. Virchows Arch. https://doi.org/10.1007/s00428-024-03908-3
Gottesdiener LS, O’Connor S, Busam KJ, Won H, Solit DB, Hyman DM, Shoushtari AN (2018Dec 1) Rates of ERBB2 alterations across melanoma subtypes and a complete response to trastuzumab emtansine in an ERBB2-amplified acral melanoma. Clin Cancer Res 24(23):5815–5819
Article CAS PubMed PubMed Central Google Scholar
Weissinger SE, Keil P, Silvers DN, Klaus BM, Möller P, Horst BA, Lennerz JK (2014Apr) A diagnostic algorithm to distinguish desmoplastic from spindle cell melanoma. Mod Pathol 27(4):524–534
Article CAS PubMed Google Scholar
Jour G, Vasudevaraja V, Prieto VG, Snuderl M, Torres-Cabala CA, Al-Rohil R, Sulman EP, Ballester LY, Aung PP (2019) BCAT1 and miR-2504: novel methylome signature distinguishes spindle/desmoplastic melanoma from superficial malignant peripheral nerve sheath tumor. Mod Pathol 32(3):338–345
Article CAS PubMed Google Scholar
Manrai PA, McHenry A, Sun T, Santin AD, Ratner E, Lin DI, Elvin JA, Hui P, Buza N (2024) Targetable ERBB2/HER2 mutations in gynecologic malignancies: clinicopathological, immunohistochemical, and molecular correlations. Int J Gynecol Pathol. https://doi.org/10.1097/PGP.0000000000001050
Amant F, Vloeberghs V, Woestenborghs H, Debiec-Rychter M, Verbist L, Moerman P, Vergote I (2004Dec) ERBB-2 gene overexpression and amplification in uterine sarcomas. Gynecol Oncol 95(3):583–587
Article CAS PubMed Google Scholar
da Costa LT, Dos Anjos LG, Kagohara LT, Torrezan GT, De Paula CAA, Baracat EC, Carraro DM, Carvalho KC (2021Jan) The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: a preliminary study. Clinics (Sao Paulo) 20(76):e2324
Kim JY, Kim B (2023May) Clinically aggressive uterine epithelioid leiomyosarcoma with rhabdomyoblastic differentiation and high proliferation rate: a case report. Am J Case Rep 16(24):e939349. https://doi.org/10.12659/AJCR.939349
Lim SH, Mansor SB, Kathirvel R, Kuick CH, Lim-Tan SK, McCluggage WG (2022Sep 1) Description of a novel ERBB4 -rearranged uterine sarcoma. Int J Gynecol Pathol 41(5):508–513
Article CAS PubMed Google Scholar
Michal M, Kuruc J, Hájková V, Michalová K, Klubíčková N (2024) S100 and CD34 positive spindle cell tumors of the uterine cervix with EGFR mutation: a hitherto unrecognized neoplasm phenotypically and epigenetically overlapping with “NTRK-rearranged spindle cell neoplasms” of the uterus. Virchows Arch. https://doi.org/10.1007/s00428-024-03936-z
Comments (0)